Most Read Articles
Stephen Padilla, 09 Nov 2020
Tocilizumab (TCZ) therapy appears to be effective in patients at risk of cytokine release syndrome (CRS) from the novel coronavirus disease (COVID-19), suggests a study presented at ID Week 2020. Those receiving TCZ in a nonintensive care unit (non-ICU) setting show better response than ICU patients.
11 Aug 2020
During the Allergic Rhinitis (AR) Boot Camp held in conjunction with the Bayer Pharmacist Congress 2020, Professor Dr Baharudin Abdullah discussed the management of AR in the primary care setting and the importance of using patient profiles to guide the choice of antihistamines.
Stephen Padilla, 10 Nov 2020
Patients with chronic obstructive pulmonary disease (COPD) seem to benefit from using chlorhexidine oral rinses twice daily as shown by the reduction in oral and sputum microbiota alpha diversity and by clinically significant improvements in COPD symptoms, according to a study presented at ID Week 2020.
Rachel Soon, 28 Aug 2020
MOH Director-General Tan Sri Dato' Seri Dr Noor Hisham Abdullah speaks about NHMS 2019 and pharmacists' roles in combating NCDs among Malaysians.

Text message reminder improves HPV vaccination rate

Elaine Soliven
14 May 2019

The use of text messaging as a reminder for the next human papillomavirus (HPV) vaccine dose may help increase the rates of HPV vaccine series completion, according to a study presented at PAS* 2019 Meeting.

“HPV vaccine is a critical cancer-protecting vaccine; yet, only half of adolescents have received their needed doses … Even among those who start the series, only three-quarters get all the doses needed for protection,” said study lead author Associate Professor Melissa Stockwell from the Department of Pediatrics, Division of Pediatric Child and Adolescent Medicine at Columbia University Irving Medical Center in New York, US.

This AHRQ**-funded study consisted of 956 parents and their adolescents aged 9–17 years (50 percent female) who underwent a first HPV vaccine at four affiliated community clinics in US between December 2014 and 2016. Participants were randomized in a 1:1 ratio to receive either conventional text message (which stated the due date for the next HPV vaccine dose) or enhanced educational text message (which included educational information for the parent’s vaccine decision-making phase). The study’s primary outcome was the completion of two or three doses of HPV vaccine at 12 months. [PAS 2019, abstract 3335.6]

Participants who were enrolled in either text messaging groups showed a significantly higher completion rate of HPV vaccine compared with individuals who were screened but not eligible to enrol in the study (74.1 percent vs 45.2 percent; p<0.0001).

A significantly higher completion rate of HPV vaccine was also observed in both text messaging groups than those participants who had their first HPV vaccine within 3 years prior to this study (71.1 percent vs 34.8 percent; p<0.0001). “Finally, a population-wide effect was seen during the years of the study 2014–2016, above historical trends,” Stockwell said.

The completion rates of HPV vaccine series at 12 months were comparable between the conventional and educational text messaging groups (75.7 percent vs 72.4 percent).

“In this study, we found that text message vaccine reminders are a powerful, rapid, and scalable way to help encourage families to have adolescents complete their vaccine series,” Stockwell noted.

 

*PAS: Pediatric Academic Societies

**AHRQ: Agency for Healthcare Research & Quality

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 09 Nov 2020
Tocilizumab (TCZ) therapy appears to be effective in patients at risk of cytokine release syndrome (CRS) from the novel coronavirus disease (COVID-19), suggests a study presented at ID Week 2020. Those receiving TCZ in a nonintensive care unit (non-ICU) setting show better response than ICU patients.
11 Aug 2020
During the Allergic Rhinitis (AR) Boot Camp held in conjunction with the Bayer Pharmacist Congress 2020, Professor Dr Baharudin Abdullah discussed the management of AR in the primary care setting and the importance of using patient profiles to guide the choice of antihistamines.
Stephen Padilla, 10 Nov 2020
Patients with chronic obstructive pulmonary disease (COPD) seem to benefit from using chlorhexidine oral rinses twice daily as shown by the reduction in oral and sputum microbiota alpha diversity and by clinically significant improvements in COPD symptoms, according to a study presented at ID Week 2020.
Rachel Soon, 28 Aug 2020
MOH Director-General Tan Sri Dato' Seri Dr Noor Hisham Abdullah speaks about NHMS 2019 and pharmacists' roles in combating NCDs among Malaysians.